All News Sensei Biotherapeutics, Inc.

Equities

SNSE

US81728A1088

Market Closed - Nasdaq Other stock markets 02:00:01 27/04/2024 am IST			5-day change	1st Jan Change
1.02 ^USD	+1.99%		+5.15%	+47.40%

24/04	Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting	CI
04/04	Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of Vista Within the Tumor Microenvironment	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting	25/04	AQ
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting	25/04	CI
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference	09/04	AQ
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment	05/04	AQ
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of Vista Within the Tumor Microenvironment	05/04	CI
Sensei Biotherapeutics : Company Presentation April 2024	02/04	PU
Sensei Biotherapeutics, Inc. Announces Resignation of Erin Colgan as Chief Financial Officer, Effective April 10, 2024	02/04	CI
North American Morning Briefing : Stocks Set for -2-	28/03	DJ
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium	22/03	AQ
Keystone Symposia 2024: Preclinical data for SNS-101	21/03	PU
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences	06/03	AQ
Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights	28/02	AQ
Sensei Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Sensei Biotherapeutics, Inc. Announces Management Changes	09/02	CI
Sensei Biotherapeutics to Present at Upcoming Conferences	07/02	AQ
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones	04/01	AQ
HC Wainwright Initiates Sensei Biotherapeutics With Buy Rating, Price Target is $4	04/12	MT
Sensei Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2023	07/11	CI
Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights	07/11	AQ
Sensei Biotherapeutics : Regulation FD Disclosure - Form 8-K	06/11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SENSEI BIOTHERAPEUTICS : Mixed Q3; but cash cushion remains intact

November 10, 2022 at 05:29 pm IST